# EDGAR Filing Document

**Accession Number:** 0002020621
**File Stem:** 0001376474-26-000001
**Filing Date:** 2026-1
**Character Count:** 16226
**Document Hash:** 67b71450e5756935ab7cd0abf5abb921
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001376474-26-000001.hdr.sgml**: 20260102

**ACCESSION NUMBER**: 0001376474-26-000001

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260102

**DATE AS OF CHANGE**: 20260102

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Innovative Eyewear Inc
- **CENTRAL INDEX KEY:** 0001808377
- **STANDARD INDUSTRIAL CLASSIFICATION:** OPHTHALMIC GOODS [3851]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 842794274
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94104
- **FILM NUMBER:** 26502620

**BUSINESS ADDRESS:**
- **STREET 1:** 11900 BISCAYNE BLVD
- **STREET 2:** STE 630
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33181
- **BUSINESS PHONE:** 786-910-1898

**MAIL ADDRESS:**
- **STREET 1:** 66 W FLAGLER ST. SUITE 900
- **STREET 2:** STE 216
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33130
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Galkin Vladimir
- **CENTRAL INDEX KEY:** 0002020621

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** 10900 NW 97TH STREET, #102
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33178

## Ex-99

# <u>Schedule A</u> 
This Schedule sets forth information with respect to each purchase and sale of Common Stock of the Issuer which were effectuated by Reporting Persons during the past sixty (60) days. All transactions were effectuated in the open market through a broker.

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; **Name of Reporting Person** | &nbsp;&nbsp; **Date of Transactions** | &nbsp;&nbsp; **Type of Transactions** | &nbsp;&nbsp; **Number of Securities** | &nbsp;&nbsp; **Price Per Share(1)** |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/04/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (2507) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.46  |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/10/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (50300) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.49  |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/11/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (8423) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.58  |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/17/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (5366) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.38 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/18/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (7600) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.38 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/19/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (4835) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.37 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/22/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (367) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.35 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/23/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (32958) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.33 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/24/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (928) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.31 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/26/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (90709) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.22 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/29/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (46107) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.10 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/30/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (11303) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1.08 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 12/31/25 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (89830) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $0.99 |
| &nbsp;&nbsp; Vladimir and Angelica Galkin | &nbsp;&nbsp; 1/2/26 | &nbsp;&nbsp; Sale | &nbsp;&nbsp; (1262) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $0.97 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(1)** The prices reported are volume weighted-average prices and include commissions paid in per share prices. These shares of Common Stock were purchased or sold in multiple transactions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased or sold at each price within the ranges set forth in this Footnote 1.

## Ex-99

**<u>Exhibit A</u>**

**JOINT FILING AGREEMENT**

This Joint Filing Agreement (this "Agreement") hereby confirms the agreement by and among all of the undersigned that the Schedule 13D to which this Agreement is attached as Exhibit A, with respect to the beneficial ownership of the undersigned shares of common stock of Innovative Eyewear, Inc, is being filed on behalf of each of the undersigned. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

---

| | | |
|:---|:---|:---|
| **Date:** January 2, 2026 | **By:** | **/s/ Vladimir Galkin** |
|  |  | **Vladimir Galkin** |
| <br>**Date:** January 2, 2026 | **By:** | **/s/ Angelica Galkin** |
|  |  | **Angelica Galkin** |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 9)**

**Innovative Eyewear Inc**

*(Name of Issuer)*

**Common Stock, par value  $0.00001 per share**

*(Title of Class of Securities)*

**45791D109**

*(CUSIP Number)*

**Vladimir Galkin**<br>10900 NW 97th Street, #102<br>Miami FL 33178<br>(310) 880-6330

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/30/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **45791D109** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Galkin Vladimir** | Name of reporting person<br>**Galkin Vladimir** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**647505.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**647505.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**647505.00** | Aggregate amount beneficially owned by each reporting person<br>**647505.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**12.1%** | Percent of class represented by amount in Row (11)<br>**12.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (1)   The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Vladimir Galkin and Angelica Galkin have shared voting power and dispositive power over 647,505 shares of Common Stock.
(2)   Based on 5,350,183 shares of the Issuer's common stock issued and outstanding as of November 6, 2025, based on information reported by the Issuer in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, and filed with the Securities and Exchange Commission (the SEC) on November 13, 2025.

| **CUSIP No.** | **45791D109** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Galkin Angelica** | Name of reporting person<br>**Galkin Angelica** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**647505.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**647505.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**647505.00** | Aggregate amount beneficially owned by each reporting person<br>**647505.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**12.1%** | Percent of class represented by amount in Row (11)<br>**12.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (1)   The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife. Vladimir Galkin and Angelica Galkin have shared voting power and dispositive power over 647,505 shares of Common Stock.
(2)   Based on 5,350,183 shares of the Issuer's common stock issued and outstanding as of November 6, 2025, based on information reported by the Issuer in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, and filed with the Securities and Exchange Commission (the SEC) on November 13, 2025.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value  $0.00001 per share

**(b) Name of Issuer:**
Innovative Eyewear Inc

**(c) Address of Issuer's Principal Executive Offices:**
11900 BISCAYNE BLVD, STE 630, MIAMI, FL, 33181

This Amendment No. 9 amends the Schedule 13D filed on September 23, 2024 (the "Original Schedule 13D" and, as amended by Amendment No. 1 to Schedule 13D filed on September 23, 2024, and as amended by Amendment No.2 to Schedule 13D filed on September 23, 2024 , and as amended by Amendment No. 3 filed on September 23, 2024, and as amended by Amendment No. 4 filed on September 24, 2024, and as amended by Amendment No. 5 filed on September 25, 2024, and as amended by Amendment No. 6 filed on October 4, 2024, and as amended by Amendment No. 7 filed on December 12, 2025, and as amended by Amendment No. 8 filed on December 29, 2025, as amended the "Schedule 13D").  This statement of beneficial ownership on Schedule 13D is jointly filed by each of Vladimir Galkin and Angelica Galkin, husband and wife (collectively, the "Reporting Persons" and individually, a "Reporting Person"), with respect to the shares of the common stock, par value $0.00001 per share (the " Common Stock"), of Innovative Eyewear, Inc., a Florida corporation (the " Issuer").  According to the Issuer, the address of its principal executive office is 1900 Biscayne Blvd., Suite 630, North Miami, Florida 33181.  Unless specifically amended hereby, the disclosures set forth in the Original Schedule 13D remain unchanged. Capitalized terms used but not otherwise defined herein have the meanings given to them in the Original Schedule 13D filed on September 23, 2024.

**Item 4. Purpose of Transaction**

Effective January 2, 2026, the Reporting Persons sold approximately 2.8% of the Issuer's outstanding Common Stock through open market transactions, since their filing of Amendment No. 8 to this Schedule 13D filed on December 29, 2025. The Reporting Persons no longer believe that the Issuer represents an attractive investment based on the Issuer's business prospects and strategy, and intend to divest of their remaining shares of Common Stock in open market transactions over the next six (6) months. The Reporting Persons do not expect to have further communications with the board of directors of the Issuer, members of management and/or other shareholders with respect to operational, strategic, financial or governance matters.  This represents a change in purpose from the initial investment.  Notwithstanding the foregoing, the Reporting Persons reserve the right to acquire, or cause to be acquired, additional securities of the Issuer, to dispose of, or cause to be disposed of, such securities at any time or to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed advisable in light of general investment and trading policies of the Reporting Persons, market conditions or other factors.
Other than as set forth above, the Reporting Persons do not have any plans or proposals as of the date of this filing which relate to or would result in any of the actions enumerated in Item 4 of the instructions to Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of the date hereof, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own 647,505 shares of Common Stock, representing approximately 12.1% of the issued and outstanding shares of Common Stock of Issuer.

**(b)**
The foregoing beneficial ownership percentages reported in this Item 5 are based on 5,350,183 shares of the Issuer's Common Stock issued and outstanding as of November 6, 2025, based on information reported by the Issuer in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, and filed with the Securities and Exchange Commission (the SEC) on November 13, 2025.

**(c)**
See Rows 7-10 of the cover page for information regarding the power to vote or direct the vote and the power to dispose or direct the disposition of the shares of Common Stock by each of the Reporting Persons.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

No person other than a Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Common Stock beneficially owned by the Reporting Persons.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Galkin Vladimir

**Signature:** Vladimir Galkin

**Name/Title:** Individual

**Date:** 01/02/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Galkin Angelica

**Signature:** Angelica Galkin

**Name/Title:** Individual

**Date:** 01/02/2026